about
Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancersDPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.Childhood onset of stiff-man syndrome.Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.Hydrocephalus in neuromyelitis optica.AQP4 autoantibody assay performance in clinical laboratory service.Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis.Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review.Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population.Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity.Adult-onset Opsoclonus-Myoclonus Syndrome Associated With Ganglionic Acetylcholine Receptor Autoantibody.Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis.Serum ferritin is elevated in amyotrophic lateral sclerosis patients.Improvement of GAD65-associated autoimmune epilepsy with testosterone replacement therapy.Emerging Subspecialties in Neurology: Autoimmune neurology.Emerging subspecialties in neurology: neuroimmunologyPurkinje cell cytoplasmic antibody type 1 (anti-Yo) autoimmunity in a child with Down syndromeAutoimmune NeurologyInfection, Immunodeficiency, and Inflammatory Diseases in Autoimmune Neurology
P50
Q27309823-293E3DF7-DCF9-4496-92AE-30A2FE6FC35DQ27312074-469B46CE-34F9-422C-B050-7EA20E146B9DQ30386799-0379BFFF-54BE-4D90-8D65-F76D15996120Q30587642-3DF04630-8014-4D1D-9BBC-1D858A29145BQ33672598-CAA32280-DC26-4CC6-868E-EE9C385D69C8Q34368662-3D8092FD-27B3-4693-A090-1B9F2BDC2622Q37697480-87FE5C38-04F5-472E-BF3C-B2DED1FD90E2Q38768583-42EC6465-35B9-4AE3-BCE0-5131BA1A38ACQ38972981-E41293C9-BD8D-4924-9072-56A36B93B8B3Q39083085-2493BD00-4FEB-4E2B-91F2-DD5AA06B1CC4Q39889728-720D5CA1-ACDE-4265-8352-6B2634A2C98FQ40472006-C0C244EB-7B38-4C87-8F31-C5685CC73B28Q41172251-9F9E7C9E-1832-4916-93BC-603231CC5094Q41673464-5167C851-B931-450E-9878-BBCD4628E62FQ42533758-EE60925A-EE78-4B4C-BA81-05A43A0309CBQ50146406-151A2A1E-D3DE-44A3-8CCB-A0D3215C3D96Q85429862-9A75853F-EE04-4951-9B3B-0FFA58AF1D4DQ87098590-C4C0673E-D188-4675-BAE1-5BF3F6DACBBDQ90242900-EFB55832-80C5-4A7D-A38B-7B9709B1B892Q90242972-BFC60614-B086-4FDA-ACA4-67A6581B3F70
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6600-9428
@en
name
Stacey L Clardy
@ast
Stacey L Clardy
@en
Stacey L Clardy
@es
Stacey L Clardy
@nl
type
label
Stacey L Clardy
@ast
Stacey L Clardy
@en
Stacey L Clardy
@es
Stacey L Clardy
@nl
prefLabel
Stacey L Clardy
@ast
Stacey L Clardy
@en
Stacey L Clardy
@es
Stacey L Clardy
@nl
P106
P1153
8731544800
P31
P496
0000-0001-6600-9428